Inari Medical Inc Ordinary Shares NARI
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NARI is a good fit for your portfolio.
News
-
ROSEN, NATIONAL TRIAL LAWYERS, Encourages Inari Medical, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NARI
-
Inari Medical, Inc. (NARI) Litigation Initiated After NARI Disclosed DOJ Probe of Business Practices – Hagens Berman
-
INARI MEDICAL, INC. (NASDAQ: NARI) INVESTOR ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Inari Medical, Inc.
-
NARI INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Inari Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
-
Inari Medical, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before July 12, 2024 to Discuss Your Rights - NARI
-
NARI Investor Alert: Kessler Topaz Meltzer & Check, LLP Urges Inari Medical, Inc. Investors with Losses to Contact the Firm
-
INARI MEDICAL SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Inari Medical, Inc. - NARI
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Li Auto, Sprout Social, Inari, and UnitedHealth and Encourages Investors to Contact the Firm
Trading Information
- Previous Close Price
- $46.39
- Day Range
- $46.13–46.69
- 52-Week Range
- $36.72–71.84
- Bid/Ask
- $46.21 / $46.55
- Market Cap
- $2.70 Bil
- Volume/Avg
- 894,822 / 1.3 Mil
Key Statistics
- Price/Earnings (Normalized)
- 498.72
- Price/Sales
- 5.13
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Inari Medical Inc is a medical device company focused on developing products to treat patients suffering from Chronic Venous Disease. Its product portfolio includes; ClotTriever, for the removal of the clot from peripheral blood vessels and treats patients suffering from deep vein thrombosis. The FlowTriever System product is used for the treatment of pulmonary embolism, InThrill system to treat small vessel thrombosis, LimFlow system and others. Geographically, the company generates majority of its revenue from United States and rest from International markets.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 1,300
- Website
- https://www.inarimedical.com
Comparables
Valuation
|
Metric
|
NARI
|
SIBN
|
LUNG
|
|---|---|---|---|
Price/Earnings (Normalized) | 498.72 | — | — |
Price/Book Value | 6.02 | 3.26 | 2.39 |
Price/Sales | 5.13 | 3.65 | 3.56 |
Price/Cash Flow | 107.13 | — | — |
Price/Earnings
NARI
SIBN
LUNG
Financial Strength
|
Metric
|
NARI
|
SIBN
|
LUNG
|
|---|---|---|---|
Quick Ratio | 2.09 | 8.63 | 5.98 |
Current Ratio | 2.71 | 9.76 | 6.95 |
Interest Coverage | −98.60 | −13.62 | −17.05 |
Quick Ratio
NARI
SIBN
LUNG
Profitability
|
Metric
|
NARI
|
SIBN
|
LUNG
|
|---|---|---|---|
Return on Assets (Normalized) | 2.99% | −7.83% | −21.78% |
Return on Equity (Normalized) | 3.92% | −10.72% | −31.74% |
Return on Invested Capital (Normalized) | 1.60% | −10.92% | −24.90% |
Return on Assets
NARI
SIBN
LUNG
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Hfrkgnsm | Rcctwdt | $187.0 Bil | |||
| Stryker Corp
SYK
| Dgfdwpndg | Pwj | $132.6 Bil | |||
| Boston Scientific Corp
BSX
| Dmtsvlz | Shdqjz | $113.8 Bil | |||
| Medtronic PLC
MDT
| Jccjlbjn | Cxzcjkp | $109.0 Bil | |||
| Edwards Lifesciences Corp
EW
| Nkmzlsgxqn | Zptdth | $51.9 Bil | |||
| DexCom Inc
DXCM
| Kpcmskpyks | Xlrb | $46.2 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Jqhrmtv | Nhhntx | $24.7 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Lgmmrmxgk | Vny | $23.3 Bil | |||
| Steris PLC
STE
| Dcdgdtlc | Blqbsl | $22.2 Bil | |||
| Align Technology Inc
ALGN
| Fsrxcpzsz | Chlmbn | $19.2 Bil |